Repro Med Systems Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 37.9% | 35.4% | 45.5% | 40.0% | 38.2% | 35.9% | 38.9% | 39.2% | 36.4% | 36.5% | 38.7% | 35.0% | 33.8% | 36.6% | 40.2% | 36.3% | 35.2% | 43.4% | 40.5% | 41.9% | 42.1% | 41.0% | 42.0% | 48.9% | 44.3% | 44.5% | 43.9% | 43.9% | 38.0% | 39.7% | 37.7% | 35.0% | 36.6% | 37.1% | 37.2% | 36.5% | 39.8% | 37.4% | 40.2% | 34.9% | 38.0% | |
| 62.1% | 64.6% | 54.5% | 60.0% | 61.8% | 64.1% | 61.1% | 60.8% | 63.6% | 63.5% | 61.3% | 65.0% | 66.2% | 63.4% | 59.8% | 63.7% | 64.8% | 56.6% | 59.5% | 58.1% | 57.9% | 59.0% | 58.0% | 51.1% | 55.7% | 55.5% | 56.1% | 56.1% | 62.0% | 60.3% | 62.3% | 65.0% | 63.4% | 62.9% | 62.8% | 63.5% | 60.2% | 62.6% | 59.8% | 65.1% | 62.0% | |
| 2.2% | 1.9% | 1.8% | 0.6% | 0.4% | 0.5% | 0.2% | 0.5% | 2.8% | 1.9% | 2.0% | 3.3% | 2.6% | 4.7% | 4.0% | 3.9% | 6.4% | 8.7% | 6.2% | 7.0% | 13.2% | 14.6% | 18.4% | 19.9% | 11.1% | 22.4% | 21.2% | 23.0% | 18.5% | 17.9% | 18.0% | 13.5% | 18.8% | 12.6% | 11.6% | 11.7% | 9.0% | 10.5% | 11.2% | 8.9% | 9.9% | |
| 61.4% | 63.7% | 54.8% | 52.4% | 49.2% | 44.2% | 46.6% | 44.9% | 48.5% | 70.0% | 59.9% | 59.4% | 36.9% | 44.9% | 43.6% | 41.5% | 50.6% | 73.7% | 55.0% | 73.9% | 64.6% | 75.2% | 87.9% | 84.5% | 62.2% | 64.8% | 73.4% | 76.5% | 66.0% | 69.8% | 65.4% | 63.1% | 62.7% | 65.9% | 61.9% | 52.8% | 57.6% | 55.4% | 55.9% | 49.3% | 54.4% | |
| 65.9% | 68.2% | 59.1% | 55.0% | 51.6% | 48.8% | 48.7% | 47.1% | 46.7% | 73.7% | 53.7% | 43.3% | 40.7% | 51.0% | 50.6% | 77.1% | 58.9% | 85.3% | 100.3% | 83.1% | 79.8% | 91.6% | 108.1% | 106.3% | 75.4% | 89.7% | 97.4% | 102.5% | 87.6% | 90.9% | 86.2% | 79.1% | 84.2% | 80.9% | 75.7% | 66.6% | 68.6% | 67.6% | 67.1% | 59.9% | 65.7% | |
| -3.8% | -3.5% | -4.6% | 5.0% | 10.2% | 14.9% | 12.4% | 13.7% | 10.6% | -10.2% | -2.3% | 0.7% | 12.5% | -2.6% | 9.2% | -13.4% | 5.9% | -28.7% | -40.8% | -25.0% | -21.9% | -32.6% | -50.1% | -55.2% | -19.7% | -34.2% | -41.3% | -46.5% | -25.6% | -30.6% | -23.9% | -14.1% | -20.8% | -18.0% | -12.9% | -3.1% | -8.3% | -5.0% | -7.4% | 5.2% | -3.7% | |
| 0.4% | 0.1% | 0.3% | 1.8% | 0.6% | 0.1% | 0.5% | 0.8% | 0.2% | 0.1% | 0.0% | 2.2% | 26.0% | 29.7% | 0.3% | 0.1% | 0.2% | 0.5% | 0.2% | 0.2% | 0.0% | 0.1% | 0.0% | 0.1% | 0.5% | 1.4% | 1.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -4.0% | -4.9% | -4.8% | 5.9% | 10.5% | 15.4% | 12.7% | 13.4% | 10.8% | -10.0% | -2.2% | 1.9% | 12.7% | -2.2% | 9.3% | -13.6% | 6.5% | -27.9% | -40.8% | -24.8% | -22.0% | -22.3% | -50.2% | -55.5% | -19.3% | -32.8% | -40.4% | -44.6% | -23.8% | -28.1% | -23.6% | -11.7% | -19.3% | -17.6% | -12.1% | -1.9% | -7.5% | -4.4% | -6.9% | 2.1% | -4.0% | |
| -1.3% | -1.7% | -0.9% | 2.0% | 3.6% | 3.7% | 2.7% | 2.8% | 2.3% | -1.7% | -0.4% | 0.5% | 2.8% | -0.9% | 2.2% | 0.4% | 2.4% | -7.4% | -17.4% | -4.4% | -3.9% | -5.8% | -9.6% | -10.8% | -3.5% | -5.9% | -7.8% | -8.7% | -4.3% | 75.8% | 2.3% | 0.0% | – | 0.0% | – | 0.2% | 0.0% | 0.0% | – | 0.0% | – | |
| -2.6% | -3.3% | -3.9% | 3.9% | 6.9% | 11.7% | 10.0% | 10.6% | 8.5% | -8.3% | -1.7% | 1.5% | 9.8% | -1.3% | 7.1% | -14.0% | 4.1% | -20.6% | -23.5% | -20.3% | -18.1% | -16.5% | -40.6% | -44.6% | -15.8% | -26.9% | -32.6% | -36.0% | -19.5% | -103.9% | -23.6% | -11.7% | -19.3% | -17.7% | -12.1% | -2.0% | -7.5% | -4.5% | -6.9% | 2.1% | -4.0% | |
| -1.6% | -2.4% | -2.3% | 7.0% | 12.2% | 16.6% | 14.3% | 15.4% | 18.6% | -8.1% | 9.3% | 23.3% | 26.8% | 13.9% | 10.6% | 18.3% | 7.8% | -25.7% | -38.6% | -22.6% | -20.1% | -20.4% | -48.4% | -53.5% | -17.2% | -30.3% | -37.5% | -41.6% | -20.7% | -24.9% | -20.8% | -9.1% | -16.5% | -16.9% | -9.8% | 0.2% | -5.5% | -2.8% | -5.2% | 3.9% | -2.3% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.